The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Tocilizumab, an anti-inflammatory drug typically used for rheumatoid arthritis, has shown promise against moderate-to-severe ...
The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
Scientists may have found a completely new way to treat depression by targeting inflammation instead of brain chemistry.
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an ...
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomized controlled clinical ...
Data published in the Journal of the American College of Cardiology Represents first peer-reviewed publication of clinical data demonstrating ...
Andes hantavirus causes deadly lung failure, but its method of attack differs from other respiratory illnesses. The details ...
The review found that bromelain may help modulate inflammatory pathways and reduce compounds associated with inflammation, ...
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomised controlled clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results